152 related articles for article (PubMed ID: 67142)
1. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
Parker GA; Rosenberg SA
J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
[TBL] [Abstract][Full Text] [Related]
2. Serologic identification of multiple tumor-associated antigens on murine sarcomas.
Parker GA; Rosenberg SA
J Natl Cancer Inst; 1977 May; 58(5):1303-9. PubMed ID: 67211
[TBL] [Abstract][Full Text] [Related]
3. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
Matsumura T; Krinock RA; Chang AE; Shu S
Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
[TBL] [Abstract][Full Text] [Related]
5. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
6. Similarities of fetal and tumor antigens of MCA-induced murine sarcomas.
Grant JP; Tschang TP; Wells SA
Surg Forum; 1974; 25(0):104-6. PubMed ID: 4439132
[No Abstract] [Full Text] [Related]
7. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
Shu S; Rosenberg SA
J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
Kahan BD; Tanaka T; Pellis NR
J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
[TBL] [Abstract][Full Text] [Related]
11. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
Chou T; Chang AE; Shu SY
J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925
[TBL] [Abstract][Full Text] [Related]
12. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy of newly induced murine sarcomas.
Shu SY; Rosenberg SA
Cancer Res; 1985 Apr; 45(4):1657-62. PubMed ID: 3872168
[TBL] [Abstract][Full Text] [Related]
14. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
15. Mouse monoclonal antibody to embryonic antigen: development, cross-reactivity with rodent and human tumors, and preliminary polypeptide characterization.
Payne WJ; Coggin JH
J Natl Cancer Inst; 1985 Sep; 75(3):527-44. PubMed ID: 2411994
[TBL] [Abstract][Full Text] [Related]
16. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
Cohen PA; Cohen PJ; Rosenberg SA; Mulé JJ
Cancer Res; 1994 Feb; 54(4):1055-8. PubMed ID: 7906197
[TBL] [Abstract][Full Text] [Related]
18. Chemical enhancement of tumor immunogenicity.
Eggers AE; Hibbard CA; Civin CI; Wunderlich JR
J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
20. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
Itoh T; Storkus WJ; Gorelik E; Lotze MT
J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
